Metraipolis › archive › dc_7ab8c8eba8ca
Non-signaling protein therapeutics: a mechanism-based regulatory framework to modernize biosimilar development and global harmonization — Europe PMC PMID:41907287
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41907287
- DOI
- 10.3389/fmed.2026.1779934
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-04T11:26:26.143Z
- SHA-256 of the archived text
9197d80910a383511d68fe570e458b055af12d528f630e2d18f1633e65c6a77e- Stable URL of this page
https://metraipolis.com/documento/dc_7ab8c8eba8ca
How to cite
Non-signaling protein therapeutics: a mechanism-based regulatory framework to modernize biosimilar development and global harmonization — Europe PMC PMID:41907287 — Europe PMC (en), https://europepmc.org/article/MED/41907287 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7ab8c8eba8ca (Metraipolis archive dc_7ab8c8eba8ca, sha256 9197d80910a383511d68fe570e458b055af12d528f630e2d18f1633e65c6a77e)
BibTeX
@misc{dc7ab8c8eba8ca,
title = {Non-signaling protein therapeutics: a mechanism-based regulatory framework to modernize biosimilar development and global harmonization — Europe PMC PMID:41907287},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41907287},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7ab8c8eba8ca; sha256 9197d80910a383511d68fe570e458b055af12d528f630e2d18f1633e65c6a77e},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41907287. Agents can read the archived copy with the MCP tool read_document.